Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. junior Avg
|
|
New words:
abdominal, ACA, ADCETRIS®and, ALCL, Anticalin, Array, ASCO, atezolizumab, auditor, Avastin, avelumab, Beleodaq, belinostat, bevacizumab, BioPharma, blinded, bona, borrow, borrowing, brain, bridge, Bristol, cardiopulmonary, Cascadian, ceiling, cervical, charitable, CHECKMATE, citing, cleanup, colorectal, competitor, confer, congestion, consortium, Council, counsel, County, CPI, CSR, cut, dealing, discernible, divestiture, donation, donor, draft, emtansine, error, exacerbated, explanation, fault, faulty, fide, flat, forenfortumab, forma, gastric, Genitourinary, goodwill, grown, Herceptin, HHS, hospital, House, HRSA, Hyponatremia, illustrating, illustrative, incentivize, infarction, Inspector, intensifying, interstitial, introduce, introduced, JanuaryForm, Justice, Kadcyla, Keytruda, ladiratuzumab, Land, landlord, landscape, leadership, loan, marginal, merge, mg, motion, multicenter, myocardial, narrow, nasal, needy, nominal, notional, occasionally, offshore, OIG, onForm, outpatient, overexpressed, palliative, Parliament, passed, PCAOB, permissible, pervasive, platform, PMA, poster, PPCCA, pralatrexate, precautionary, premarket, printing, pro, processing, prostate, proven, pyrexia, ramucirumab, recurrent, reproducible, reset, restraint, revalued, romidepsin, satisfaction, SEC, Senate, Snohomish, sodium, sought, speculative, stay, staying, stipulating, suit, surgery, taxation, TEAE, Tecentriq, thereof, thereto, therewith, tighter, tisotumab, TKI, trail, tucatinib, tyrosine, unblind, unblinded, unblinding, undermine, underperform, unmet, unresolved, unspecified, urge, urinary, validly, Valley, vast, vitroandin, waiver, White, wholly, withdrawn, withdrew, withholding, women
Removed:
accessed, adding, administrator, AETHERA, aggressive, aimed, ALCANZA, alive, Arizona, bexarotene, blocking, call, chemical, choice, chronic, crizotinib, cytarabine, daunorubicin, diffuse, dimer, dividend, endeavor, escalating, escalation, estimation, feet, fever, flushing, follicular, hair, headcount, highest, hypomethylating, ibrutinib, idelalisib, incomplete, induction, intensive, lymphoblastic, lymphocytic, methotrexate, molecular, mortality, newest, noncancelable, notably, offsite, optioned, pharmacokinetic, platelet, premedication, programmed, protein, radiotherapy, remained, retainable, rituximab, sponsored, square, stably, summarized, supporting, syndrome, thrombocytopenia, tolerated, transferability, unchanged, vii, virtually, vivo
Filing tables
Filing exhibits
Related press release
Associated SGEN transcripts
SGEN similar filings
Filing view
External links